Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
SGRX · Nasdaq · United States · Finance Services
In shortSANGRIX INC. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | – | n/a |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | – | n/a |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -502.6% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | – | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 4 | 0/100 |
| Revenue growth volatility | 45.3% | 0/100 |
| Operating margin volatility | 3551.3% | 0/100 |
Weight in the score: 20%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 6.3 | 6.3 | 2.9 | 0 | – |
| Cost of revenue | 11 | 11 | 3.8 | – | – |
| Gross profit | (4.6) | (4.6) | (0.9) | 0 | – |
| Operating income | (28) | (28) | (15) | (3) | (14) |
| Interest expense | 0.1 | 0.2 | 0.6 | 0.7 | – |
| Pre-tax income | (28) | (28) | (18) | (4.4) | (14) |
| Net income | 3.2 | (28) | (18) | (6.5) | (24) |
| Diluted EPS | −$8.61 | – | −$1,003.41 | −$84.84 | −$70.43 |
| Diluted shares (millions) | 3.3 | 3.3 | 0 | 0.1 | 0.3 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: the model does not apply to banks and insurers.
3/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Sep 18, 2026